Sophie Fédrizzi

Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer

Charles Dolladille, Stéphane Éderhy, Marion Sassier et al. · JAMA Oncology · 2020 · 582 citations · Full text

Medicine, Oncology, Pharmacology +17

Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012

Nadine Petitpain, Ludovic Argoullon, Kamel Masmoudi et al. · Allergy · 2018 · 50 citations

Medicine, Pharmacology, Anesthesia +16

Haematologic malignancies associated with clozapine <i>v.</i> all other antipsychotic agents: a pharmacovigilance study in VigiBase^®

Basile Chrétien, Véronique Lelong‐Boulouard, Sylvain Chantepie et al. · Psychological Medicine · 2020 · 40 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Association Between Disease-Modifying Therapies Prescribed to Persons with Multiple Sclerosis and Cancer: a WHO Pharmacovigilance Database Analysis

Charles Dolladille, Basile Chrétien, Laure Peyro‐Saint‐Paul et al. · Neurotherapeutics · 2021 · 35 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

Cushing’s syndrome due to interaction between ritonavir or cobicistat and corticosteroids: a case–control study in the French Pharmacovigilance Database

Laure Peyro‐Saint‐Paul, Paul Besnier, Ludivine Demessine et al. · Journal of Antimicrobial Chemotherapy · 2019 · 26 citations

Pharmacy, Pharmacology, Pharmacotherapy +17